Vibhuti Shah | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Vibhuti Shah | Medicine and Dentistry | Best Researcher Award

MD, FRCPC at Mount Sinai Hospital, Canada

Dr. Vibhuti Shah is a distinguished neonatologist, clinical epidemiologist, and professor at the University of Toronto, with over two decades of expertise in pediatric research. She serves as Chair of the Research Ethics Board at Mount Sinai Hospital and has played a pivotal role in advancing neonatal care through her extensive research. Holding multiple prestigious qualifications, including an MSc in Clinical Epidemiology, MRCPCH (UK), and FRCPC (Canada), she has been recognized internationally for her contributions, receiving awards such as the Patil Award (AMEE, UK) and invitations from JAMA’s “Author in the Room” program. Dr. Shah’s leadership in academia and research ethics, combined with her mentorship of future medical professionals, underscores her commitment to improving neonatal outcomes. Her work has significantly impacted clinical guidelines and patient care, making her a strong contender for the Best Researcher Award. Her dedication to research excellence continues to shape advancements in neonatology and pediatrics globally.

Professional Profile

Education

Dr. Vibhuti Shah has an extensive educational background in medicine, pediatrics, and clinical research. She earned her MBBS from the University of Bombay in 1982, followed by a Diploma in Child Health (DCH) in 1986 and an MD in Pediatrics in 1987. Further advancing her expertise, she obtained the prestigious MRCP (UK) in 1994 and MRCPCH (UK) in 1997, signifying her specialization in pediatrics and child health. She later achieved the FRCPC (Paediatrics) from the Royal College of Physicians and Surgeons of Canada in 2005, cementing her reputation in the field. Committed to research excellence, Dr. Shah pursued an MSc in Clinical Epidemiology and Healthcare Research at the University of Toronto in 2007. Her extensive training includes fellowships in neonatology and perinatal medicine in India, the UK, and Canada. This strong academic foundation has enabled her to contribute significantly to neonatal research, ethics, and healthcare advancements.

Professional Experience

Dr. Vibhuti Shah has an extensive professional career spanning clinical practice, research, and academic leadership in neonatology and pediatrics. She is a Professor in the Department of Pediatrics and the Institute of Health Policy, Management, and Evaluation at the University of Toronto and a Staff Neonatologist and Clinical Epidemiologist at Mount Sinai Hospital. She also chairs the Research Ethics Board at Mount Sinai Hospital and Humber River Hospital, overseeing research integrity and compliance. Previously, she served as Interim Co-Chair of the Research Ethics Board and held clinical fellowships in neonatology in Canada, the UK, and India. She has been an Associate Member of the School of Graduate Studies at the University of Toronto since 2008 and has contributed significantly to mentoring and training medical professionals. With decades of experience in research, clinical care, and ethics, Dr. Shah has played a vital role in shaping neonatal healthcare policies and advancing pediatric medicine.

Research Interest

Dr. Vibhuti Shah’s research interests focus on neonatal-perinatal medicine, clinical epidemiology, and healthcare ethics, with a strong emphasis on improving neonatal outcomes through evidence-based interventions. She has conducted extensive research on pain management in neonates, neonatal resuscitation, and perinatal care strategies, contributing to clinical guidelines that enhance patient care. Her work in clinical epidemiology involves evaluating healthcare interventions, systematic reviews, and meta-analyses to improve neonatal and pediatric care practices. As Chair of the Research Ethics Board at Mount Sinai Hospital, she is also deeply engaged in research ethics, ensuring the ethical conduct of clinical trials and healthcare studies. Additionally, Dr. Shah has been involved in health policy research, focusing on optimizing neonatal healthcare delivery. Her contributions, recognized by prestigious international awards, continue to shape neonatal clinical practices and influence medical education, making a significant impact on global pediatric research and patient care.

Award and Honor

Dr. Vibhuti Shah has received numerous prestigious awards and honors in recognition of her contributions to neonatal research, medical education, and clinical epidemiology. Internationally, she was awarded the Patil Award by the Association for Medical Education in Europe (AMEE, UK) for her work in teaching and learning. She was also selected for the Mid-Atlantic Conference on Perinatal Research in both 2005 and 2006, receiving travel awards for her groundbreaking research in neonatology. In 2006, she was honored with the Thomas Jefferson Honorarium and Speakership for her clinical research contributions. Additionally, she was selected by the Journal of the American Medical Association (JAMA) for its “Author in the Room” program, recognizing her impactful research on neonatal pain management. These accolades underscore Dr. Shah’s exceptional leadership, innovation, and commitment to advancing neonatal healthcare, making her a highly respected figure in the global pediatric research community.

Research Skill

Dr. Vibhuti Shah possesses a diverse set of research skills that have significantly contributed to advancements in neonatal-perinatal medicine and clinical epidemiology. She is highly proficient in clinical trial design, systematic reviews, meta-analyses, and evidence-based medicine, ensuring that neonatal healthcare practices are guided by robust scientific evidence. Her expertise in biostatistics and data analysis allows her to critically evaluate healthcare interventions and contribute to policy changes. As Chair of the Research Ethics Board at Mount Sinai Hospital, she has extensive experience in research ethics, protocol development, and regulatory compliance, ensuring the integrity of clinical studies. Dr. Shah is also skilled in grant writing, peer-reviewed publishing, and mentoring young researchers, fostering innovation in pediatric research. Her ability to integrate clinical epidemiology with neonatology has led to impactful findings that have shaped neonatal care guidelines, demonstrating her strong analytical, ethical, and leadership capabilities in research.

Conclusion

Dr. Vibhuti Shah is an exceptionally strong candidate for the Best Researcher Award due to her outstanding contributions to neonatology, clinical epidemiology, and medical ethics research. While she has already earned international recognition, additional emphasis on research impact metrics and global collaboration could make her case even stronger.

Publications Top Noted

  1. Shah VK, Firmal P, Alam A, Ganguly D, Chattopadhyay S. (2020). Overview of immune response during SARS-CoV-2 infection: lessons from the past. Frontiers in Immunology, 11, 1949. https://pubmed.ncbi.nlm.nih.gov/32849654
    Cited by: 548

  2. Firmal P, Shah VK, Chattopadhyay S. (2020). Insight into TLR4-mediated immunomodulation in normal pregnancy and related disorders. Frontiers in Immunology, 11, 807.
    Cited by: 105

  3. Pant R, Firmal P, Shah VK, Alam A, Chattopadhyay S. (2021). Epigenetic regulation of adipogenesis in development of metabolic syndrome. Frontiers in Cell and Developmental Biology, 8, 619888.
    Cited by: 52

  4. Choksi A, Parulekar A, Pant R, Shah VK, Nimma R, Firmal P, Singh S, et al. (2021). Tumor suppressor SMAR1 regulates PKM alternative splicing by HDAC6-mediated deacetylation of PTBP1. Cancer & Metabolism, 9, 1-17.
    Cited by: 23

  5. Alam A, Taye N, Patel S, Thube M, Mullick J, Shah VK, Pant R, et al. (2019). SMAR1 favors immunosurveillance of cancer cells by modulating calnexin and MHC I expression. Neoplasia, 21(10), 945-962.
    Cited by: 19

  6. Firmal P, Shah VK, Pant R, Chattopadhyay S. (2022). RING finger protein TOPORS modulates the expression of tumor suppressor SMAR1 in colorectal cancer via the TLR4‐TRIF pathway. Molecular Oncology, 16(7), 1523-1540.
    Cited by: 6

  7. Pant R, Alam A, Choksi A, Shah VK, Firmal P, Chattopadhyay S. (2021). Chromatin remodeling protein SMAR1 regulates adipogenesis by modulating the expression of PPARγ. Biochimica et Biophysica Acta (BBA) – Molecular and Cell Biology of Lipids.
    Cited by: 3

  8. Sharma A, Garg S, Shah V, Agrawal P, Lohan P. (2015). Basics of design: lessons from walled city of Jaipur.
    Cited by: 2

Thomas Wild | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Thomas Wild | Medicine and Dentistry | Best Researcher Award

Senoir Consultant at Praxis Dr. Thomas Wild, Germany

Dr. Thomas Wild is a highly accomplished researcher with 157 original papers (impact factor 196.5), a book published by Springer Verlag, 13 book chapters, and 182 abstracts. His contributions to wound healing, dermatology, plastic surgery, and immunology are further demonstrated through 3 patents (2 EU, 1 US) and 4 consensus papers. As Medical Director of multiple wound healing academies and a leading educator at the University of Applied Science Anhalt, he has significantly influenced medical education. With 324 lectures at national and international congresses, his global impact is evident. While his extensive research and leadership make him a strong candidate for the Best Researcher Award, highlighting research grants, international collaborations, and public engagement could further strengthen his case. Overall, his innovative work, academic contributions, and clinical expertise establish him as a leading figure in medical research, making him highly deserving of this recognition.

Professional Profile 

Education

Dr. Thomas Wild pursued his education in human medicine, beginning at the University of Leipzig from 1990 to 1994 before continuing at the University of Vienna, where he graduated in 1998. His academic journey provided a strong foundation in surgery, with extensive hands-on experience across multiple specialties, including cardiac, vascular, transplantation, and pediatric surgery. Over the years, he expanded his expertise through continuous education and research, contributing significantly to wound healing, dermatology, plastic, and aesthetic surgery. Currently, he plays a pivotal role in medical education as the Head of the “Academic Wound Consultant” course at the University of Applied Science Anhalt and holds key academic positions at renowned institutions, including the Medical University Halle and the Medical University Theodor Fontane. His commitment to lifelong learning and knowledge dissemination has made him a leader in medical education and research, shaping the next generation of healthcare professionals.

Professional Experience

Dr. Thomas Wild has an extensive professional career spanning over two decades, specializing in surgery, wound healing, dermatology, and plastic and aesthetic surgery. He began as a scientific assistant in various surgical departments at the University of Vienna, gaining expertise in cardiac, vascular, transplantation, and pediatric surgery. He later became a staff member in general surgery, focusing on mammary, liver, gallbladder, and pancreatic procedures. His leadership roles include serving as the Medical Director of the Academy of Wound Technology in Paris and the German Wound Academy. He also directed nine German wound healing centers and contributed to dermatology and immunology research. Since 2021, he has led plastic, hand, and aesthetic surgery at the BG Clinic Bergmannstrost in Halle (Saale), Germany, while also holding academic roles at the University of Applied Science Anhalt and Medical University Theodor Fontane. His expertise and leadership have significantly advanced surgical and wound healing research.

Research Interest

Dr. Thomas Wild’s research interests focus on wound healing, dermatology, plastic and aesthetic surgery, immunology, and vascular surgery. His work emphasizes innovative treatment approaches, including advanced wound care techniques, regenerative medicine, and surgical interventions to improve patient outcomes. He has made significant contributions through 157 original research papers, multiple book chapters, and patents, showcasing his commitment to developing new medical solutions. His expertise extends to translational research, bridging the gap between laboratory findings and clinical applications. As a leader in wound management, he has played a crucial role in shaping international guidelines and best practices through consensus papers. Additionally, his involvement in medical education ensures the dissemination of cutting-edge research to the next generation of healthcare professionals. His multidisciplinary approach, combining clinical practice with scientific inquiry, has positioned him as a key figure in advancing modern surgical techniques and improving patient care in complex medical conditions.

Award and Honor

Dr. Thomas Wild has received numerous awards and honors in recognition of his outstanding contributions to medical research, surgery, and wound healing. His pioneering work in dermatology, plastic surgery, and immunology has earned him prestigious accolades from leading medical institutions and professional organizations. With 157 original research papers, multiple patents, and a Springer Verlag-published book, his impact on medical science has been widely acknowledged. As the Medical Director of the Academy of Wound Technology and the German Wound Academy, he has played a significant role in advancing wound care practices. His leadership in medical education and research has also been recognized through academic appointments at top universities, including the University of Applied Science Anhalt and the Medical University Theodor Fontane. Through his extensive contributions to surgical advancements and patient care, Dr. Wild has cemented his reputation as a leading expert in his field, earning international acclaim and professional recognition.

Research Skill

Dr. Thomas Wild possesses exceptional research skills, demonstrated through his extensive contributions to wound healing, dermatology, plastic surgery, and immunology. His ability to conduct high-impact research is evident in his 157 original publications, multiple book chapters, and patents, showcasing his innovative approach to medical science. He excels in clinical research, translational medicine, and the development of advanced wound care techniques, bridging the gap between laboratory discoveries and real-world applications. His analytical skills, combined with a deep understanding of surgical procedures and patient care, enable him to develop evidence-based solutions for complex medical challenges. Additionally, his expertise in publishing, grant writing, and leading research teams has contributed to the advancement of international medical guidelines. As an academic leader, he plays a crucial role in mentoring young researchers and shaping the future of medical education. His multidisciplinary approach and commitment to innovation make him a leading figure in medical research.

Conclusion

Dr. Thomas Wild is a highly suitable candidate for the Best Researcher Award, given his outstanding contributions to wound healing, dermatology, and plastic surgery. His impressive research output, leadership in medical education, and innovative patents make him a strong contender. Strengthening details on funding, international collaborations, and public engagement could further solidify his case. Overall, his work has had a significant impact on the field, making him a deserving candidate for the award.

Publications Top Noted

  • Hallas, S., Nelson, E.A., O’Meara, S.M., Tawfick, W.A., Wild, T. (2024). Development of a core outcome set for use in research evaluations of interventions for venous leg ulceration: International eDelphi consensus. Journal of Tissue Viability

  • Wild, T., Aljowder, A.A., AlJawder, A.A.A., Marotz, J., Siemers, F. From Wound to Scar: Scarring Explained—Pathophysiology of Wound Healing. [Book Chapter] – 1 Citation

  • Traber, J., Wild, T., Marotz, J., Berli, M.C., Franco-Obregón, A. (2023). Concurrent Optical- and Magnetic-Stimulation-Induced Changes on Wound Healing Parameters, Analyzed by Hyperspectral Imaging: An Exploratory Case Series. Bioengineering – 6 Citations

  • Snyder, R.J., Driver, V.R., Cole, W.E., Kaufman, J.P., Wild, T. (2023). Topical Autologous Blood Clot Therapy: Consensus Panel Recommendations to Guide Use in the Treatment of Complex Wound Types. Wounds – 1 Citation

  • Snyder, R.J., Driver, V.R., Cole, W.E., Kaufman, J.P., Wild, T. (2022). Topical Autologous Blood Clot Therapy: An Introduction and Development of Consensus Panel to Guide Use in the Treatment of Complex Wound Types. Wounds – 3 Citations

  • Hallas, S., Nelson, E.A., O’Meara, S.M., Wild, T., Gethin, G. (2021). Development of a core outcome set for venous leg ulceration (CoreVen) research evaluations (protocol). Journal of Tissue Viability – 3 Citations

  • Marotz, J., Schulz, T., Seider, S., Wild, T., Siemers, F. (2021). 3D-perfusion analysis of burn wounds using hyperspectral imaging. Burns – 13 Citations

  • Zouboulis, C.C., Wild, T., Zouboulis, V.A., Har-Shai, Y. (2021). Intralesional cryosurgery of keloids: required treatment hold time. British Journal of Dermatology – 7 Citations

Deniz Esin Tekcan Sanli | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Assoc. Prof. Dr. Deniz Esin Tekcan Sanli | Medicine and Dentistry | Best Researcher Award

Faculty Member at Gaziantep University, Faculty of Medicine, Turkey

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı is a distinguished radiologist and researcher specializing in breast imaging, oncological radiology, and artificial intelligence applications in medical diagnostics. Currently serving at Gaziantep University, she holds a European Diploma in Radiology and multiple academic certifications, reflecting her expertise. With a strong research portfolio, she has published extensively in high-impact journals, including the New England Journal of Medicine and Academic Radiology. Her work focuses on improving diagnostic accuracy in breast cancer and exploring advanced imaging techniques. In addition to her medical background, she holds a master’s degree in breast imaging technologies and an associate degree in English translation, showcasing her interdisciplinary skills. Recognized for her contributions to radiology, she continues to advance the field through international collaborations and innovative research. Her commitment to academic excellence and clinical advancements makes her a strong candidate for prestigious research awards in medical science.

Professional Profile

Education

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı has a comprehensive educational background in medicine and radiology. She earned her medical degree from Ege University Faculty of Medicine in 2010, followed by a specialization in radiology at Istanbul University Cerrahpaşa Faculty of Medicine, where she conducted research on advanced imaging techniques for Crohn’s disease. She further specialized in breast imaging, completing a thesis-based master’s degree at Acıbadem Mehmet Ali Aydınlar University’s Senology Research Institute, focusing on tumor size correlation in breast cancer. In addition to her medical education, she pursued an associate degree in Applied English and Translation at Istanbul Arel University, demonstrating her interdisciplinary expertise. Her academic achievements are complemented by prestigious certifications, including the European Diploma in Radiology (EDIR) and the Turkish Society of Radiology Proficiency Test (TRD), highlighting her commitment to continuous learning and excellence in radiology.

Professional Experience

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı has extensive professional experience in radiology, medical education, and research. She currently serves as an Associate Professor at Gaziantep University, Faculty of Medicine, Department of Radiology, where she contributes to clinical practice, academic teaching, and advanced imaging research. Previously, she worked as an Assistant Professor at both Gaziantep University and Istanbul Rumeli University, gaining experience in medical education and training future healthcare professionals. Her career began as a Research Assistant at Istanbul University Cerrahpaşa Faculty of Medicine, where she conducted specialized research in diagnostic imaging. Over the years, she has earned several professional certifications, including the European Diploma in Radiology (EDIR) and the Interventional Radiology Diploma (TGRD), demonstrating her expertise in both diagnostic and interventional radiology. With a strong publication record and contributions to international collaborations, she continues to make significant advancements in the field of radiology and medical imaging.

Research Interest

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı’s research interests focus on radiology, breast imaging, oncological diagnostics, and artificial intelligence applications in medical imaging. She is particularly dedicated to improving diagnostic accuracy in breast cancer, with research exploring the correlation between radiological and pathological tumor sizes based on molecular subtypes. Her work also extends to advanced imaging techniques for gastrointestinal diseases, as demonstrated by her studies on Crohn’s disease diagnostics. Additionally, she investigates the role of artificial intelligence in early breast cancer detection, aiming to enhance radiological efficiency and reduce unnecessary biopsies. Her interdisciplinary approach, combining medical imaging with AI and statistical modeling, contributes to innovations in diagnostic radiology. Through international collaborations and high-impact publications, she continues to advance the field, striving to improve precision medicine and patient outcomes in oncology and radiology. Her research plays a vital role in shaping future imaging techniques and clinical practices.

Award and Honor

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı has received several prestigious awards and honors in recognition of her contributions to radiology and medical research. She holds the European Diploma in Radiology (EDIR), a distinguished certification granted by the European Society of Radiology, highlighting her expertise in diagnostic imaging. She also earned the Interventional Radiology Diploma (TGRD) after successfully completing rigorous training and examinations in Turkey. Additionally, she was awarded the Turkish Society of Radiology Proficiency Test (TRD) Certification, further demonstrating her excellence in the field. Her research has been published in high-impact journals such as the New England Journal of Medicine and Academic Radiology, earning her recognition in the global medical community. Through her dedication to advancing radiology, she continues to contribute to innovative imaging techniques and cancer diagnostics, positioning herself as a leading researcher in her field. Her achievements reflect her commitment to academic and clinical excellence.

Research Skill

Assoc. Prof. Dr. Deniz Esin Tekcan Şanlı’s research interests focus on radiology, breast imaging, oncological diagnostics, and artificial intelligence applications in medical imaging. She is particularly dedicated to improving diagnostic accuracy in breast cancer, with research exploring the correlation between radiological and pathological tumor sizes based on molecular subtypes. Her work also extends to advanced imaging techniques for gastrointestinal diseases, as demonstrated by her studies on Crohn’s disease diagnostics. Additionally, she investigates the role of artificial intelligence in early breast cancer detection, aiming to enhance radiological efficiency and reduce unnecessary biopsies. Her interdisciplinary approach, combining medical imaging with AI and statistical modeling, contributes to innovations in diagnostic radiology. Through international collaborations and high-impact publications, she continues to advance the field, striving to improve precision medicine and patient outcomes in oncology and radiology. Her research plays a vital role in shaping future imaging techniques and clinical practices.

Conclusion

Dr. Deniz Esin Tekcan Şanlı is a highly qualified researcher with significant contributions to radiology and oncology, making her a strong candidate for the Best Researcher Award. Her extensive publication record, academic achievements, and interdisciplinary expertise stand out. Strengthening her profile with more leadership roles in major research projects, grant acquisition, and innovation-related contributions would further solidify her candidacy.

Publications Top Noted

  • Gastrointestinal Kaposi’s Sarcoma
    Authors: Deniz Esin Tekcan Şanlı, Şafak Kızıltaş
    Year: 2023
    Citation: New England Journal of Medicine (NEJM), 2023. https://www.nejm.org/doi/pdf/10.1056/NEJMicm2102502

  • Correlation of Radiological and Pathological Tumor Sizes in Breast Cancer Based on Molecular Subtypes and Accompanying DCIS
    Authors: Deniz Esin Tekcan Şanlı, Gül Esen Icten, et al.
    Year: 2025
    Citation: Academic Radiology, https://doi.org/10.1016/j.acra.2025.01.037

  • Artificial Intelligence for Early Detection of Breast Cancer
    Authors: TEKCAN ŞANLI DENİZ ESİN, ALAKUŞ HAKAN
    Year: 2024
    Citation: Die Onkologie, DOI: 10.1007/s00761-024-01654-4

  • Prognostic Factors Affecting Survival of Patients With Single Primary Breast Cancer vs Patients With Multiple Primary Cancers in Lifetime, One of Which is Breast Cancer
    Authors: Sanli AN, Tekcan Sanli DE, Altundag MK, Aydogan F
    Year: 2024
    Citation: Am Surg., 2024; 90(11):2745-2755. DOI: 10.1177/00031348241248695

  • Should the Breast Cancer Staging System be Revised?
    Authors: Sanli AN, Tekcan Sanli DE, Aydogan F, Altundag MK
    Year: 2024
    Citation: Am Surg., 2024; 90(5):1066-1073. DOI: 10.1177/00031348231223074

  • Is There a Survival Difference Between Male and Female Breast Cancer Subtypes According to the Prognostic Staging System? A Population-Based Cohort Study
    Authors: Sanli AN, Tekcan Sanli DE, Altundag MK, Aydogan F
    Year: 2024
    Citation: Am Surg., 2024; 90(4):788-799. DOI: 10.1177/00031348231212588

  • Secretory Carcinoma of Breast: A Population-Based Study
    Authors: Sanli AN, Tekcan Sanli DE, Altundag MK, Aydogan F
    Year: 2024
    Citation: Am Surg., 2024; 90(2):252-260. DOI: 10.1177/00031348231199174

  • Linear Regression Modeling-Based Scoring System to Reduce Benign Breast Biopsies Using Multi-Parametric US with Color Doppler and SWE
    Authors: Erkin Arıbal, Burcu Özdemir, Onur Buğdaycı, Gökhan Ertaş, Deniz E T Şanlı, Handan Kaya
    Year: 2023
    Citation: Academic Radiology, https://doi.org/10.1016/j.acra.2023.01.024

  • Could DTI Unlock the Mystery of Subjective Tinnitus?
    Authors: YILMAZ EREN, YILDIRIM DÜZGÜN, TEKCAN ŞANLI DENİZ ESİN, ELPEN KARYEMEZ FATMA PINAR, et al.
    Year: 2024
    Citation: Indian Journal of Otolaryngology and Head & Neck Surgery, 76, 5277-5284. DOI: 10.1007/s12070-024-04963-7

  • Comparison of Magnetic Seed and RFID Methods in the Localization of Non-Palpable Breast Lesions
    Authors: ŞANLI AHMET NECATİ, TEKCAN ŞANLI DENİZ ESİN, et al.
    Year: 2024
    Citation: Journal of Cancer Research and Therapeutics, 20(5), 1435-1439. DOI: 10.4103/jcrt.jcrt_2253_22

  • CT-Guided Percutaneous Biopsies in the Abdomen and Pelvis
    Authors: TEKCAN ŞANLI DENİZ ESİN, WEBER JEAN PHILIP, MAINTZ DAVID
    Year: 2024
    Citation: Die Onkologie, 30, 875-876. DOI: 10.1007/s00761-024-01576-1

  • Normative Reference Values of Major Thoracic Arterial Vasculature in Turkey
    Authors: Deniz Esin Tekcan Şanlı, Ahmet Necati Şanlı, Onur Yıldırım, Ergin Erginöz, Düzgün Yıldırım
    Year: 2023
    Citation: Northern Clinics of Istanbul, DOI: 10.14744/nci.2021.03206

  • Evaluating Portal Vein and Right Colon Venous Vascular Anatomy and Its Variations via Multidetector CT in Healthy Individuals
    Authors: Uludag, S.S., Kurt, S.A., Sanli, D.E.T. et al.
    Year: 2022
    Citation: Indian Journal of Surgery, 84, 1292–1302. DOI: 10.1007/s12262-022-03583-1

  • CT Findings of the Massive Air Embolism in a Case with Thoracic Gunshot Wound: A Special Case Report as if a Whole Body Pneumo-Angiography was Performed
    Authors: Zeynalova, Amalya; Sanli, Deniz E.T.; Agar, Emir H.; Yildirim, Duzgun; Tuzuner, Filiz
    Year: 2022
    Citation: Current Medical Imaging, 18(11), 1253-1256. DOI: 10.2174/0929866529666220426121222

  • A New Imaging Sign in COVID-19 Pneumonia: Vascular Changes and Their Correlation with Clinical Severity of the Disease
    Authors: Tekcan Şanlı DE, Yıldırım D.
    Year: 2020
    Citation: Diagnostic and Interventional Radiology, DOI: 10.5152/dir.2020.20346

Raj Ramesar | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Prof. Raj Ramesar | Medicine and Dentistry | Best Researcher Award

Director: Research Unit at The University of Cape Town, South Africa

Prof. Raj Ramesar is a distinguished geneticist and researcher specializing in human genetics, genomics, and precision medicine. As Head of the Division of Human Genetics and Director of the MRC Genomics and Precision Medicine Research Unit at the University of Cape Town (UCT), he has made pioneering contributions to understanding the genetic basis of hereditary cancers, particularly familial colorectal cancer. His work has led to advancements in genetic testing, risk assessment, and clinical management, earning international recognition, including the Human Genome Organisation (HUGO) Africa Award and the UCT Vice-Chancellor’s Alan Pifer Award for Research Excellence. Prof. Ramesar has played a key role in developing genomic research infrastructure in Africa, collaborating on global initiatives, supervising numerous PhD theses, and advancing precision medicine applications. His research extends to inherited retinal disorders, contributing to clinical trials for genetic blindness treatments. His leadership continues to shape genomic medicine for public health benefits in Africa and beyond.

Professional Profile 

Education

Prof. Raj Ramesar obtained his academic and professional training in human genetics, laying a strong foundation for his contributions to medical genomics. He earned his Ph.D. in Human Genetics from the University of Cape Town (UCT), where he later became a leading academic and researcher. His postgraduate studies focused on the genetic basis of hereditary cancers and inherited disorders, which positioned him at the forefront of genomic medicine in Africa. Over the years, he has engaged in numerous advanced training programs and international collaborations, enhancing his expertise in precision medicine, genomic research, and bioinformatics. As an educator, he has mentored numerous postgraduate students and played a pivotal role in developing genetic research infrastructure in South Africa. His commitment to education extends beyond the university, as he actively participates in initiatives that promote genetic literacy and capacity-building in Africa. His academic journey reflects a deep commitment to advancing genetic research and education globally.

Professional Experience

Prof. Raj Ramesar is a distinguished geneticist with a career spanning several decades, primarily at the University of Cape Town (UCT). He serves as the Head of the Division of Human Genetics and the Department of Pathology at UCT and its affiliated hospitals.

SAMRC

Prof. Ramesar is also the Director of the South African Medical Research Council’s (SAMRC) Genomic and Precision Medicine Research Unit, where he leads research on the genetic underpinnings of inherited cancers and retinal degenerative disorders.

Institute of Development Management

His work has been instrumental in identifying novel genes and mutations within South African populations, with a recent focus on genetic studies in indigenous African communities. Beyond his research, he contributes to the scientific community by serving on editorial boards of international journals and holding leadership roles, including chairing the board of the Africa Genome Education Institute.

African Scientists

Prof. Ramesar’s professional journey reflects a steadfast commitment to advancing human genetics and improving health outcomes through precision medicine.

Research Interest

Prof. Raj Ramesar’s research interests primarily focus on human genetics, with a strong emphasis on hereditary cancers, inherited disorders, and genomic medicine. His work explores the genetic basis of diseases such as colorectal cancer and retinal dystrophies, aiming to develop early detection strategies and targeted therapies. He is deeply involved in precision medicine, leveraging genomic data to tailor healthcare solutions for diverse populations, particularly in Africa. His research also extends to bioinformatics, gene-environment interactions, and ethical considerations in genetic research. As a leader in African genomics, he is dedicated to addressing health disparities through genetic studies, fostering translational research that bridges the gap between laboratory discoveries and clinical applications. Additionally, he actively contributes to capacity-building initiatives, training researchers and clinicians in genomic methodologies. His work has significant implications for personalized medicine, public health policy, and the integration of genetic research into mainstream healthcare systems.

Award and Honor

Prof. Raj Ramesar, Head of the Division of Human Genetics at the University of Cape Town (UCT), has been honored with several prestigious awards recognizing his significant contributions to human genetics. In 2009, he received the UCT Vice-Chancellor’s Alan Pifer Award for his impactful research.

h3africa.org

In 2015, he was elected to the UCT College of Fellows, acknowledging his exceptional academic achievements.

ResearchGate

The following year, Prof. Ramesar was awarded the inaugural Africa Award by the Human Genome Organisation (HUGO) in recognition of his outstanding contributions to human genetics on the continent.

Health Sciences UCT

More recently, he was nominated for the NSTF-South32 Lifetime Award, further highlighting his enduring impact in the field.

Research Skill

Prof. Raj Ramesar possesses extensive research skills in human genetics, genomic medicine, and molecular biology. His expertise lies in identifying genetic markers associated with inherited diseases, particularly in the African population. He has mastered advanced genomic sequencing techniques, bioinformatics analysis, and molecular diagnostics to uncover genetic predispositions to conditions such as inherited cancers and retinal degenerative disorders. His research involves interdisciplinary collaboration, integrating clinical data with genetic insights to develop precision medicine approaches. Prof. Ramesar is highly skilled in genetic epidemiology, population genetics, and translational research, ensuring that scientific discoveries have practical healthcare applications. His ability to lead large-scale genomic studies, mentor young researchers, and contribute to global genetic research initiatives underscores his scientific acumen. He has also played a pivotal role in establishing genetic research frameworks in South Africa, promoting ethical research practices, and advancing the field of genomic medicine in Africa and beyond.

Conclusion

Dr. Rajkumar Ramesar is highly suitable for the Best Researcher Award. His outstanding contributions to human genetics, leadership in genomic research, and commitment to capacity-building in Africa make him a strong candidate. With his international recognition, innovative research, and dedication to precision medicine, he exemplifies the qualities of an award-winning researcher.

Publications Top Noted

  • Distinct Dysregulated Pathways in Sporadic and Lynch Syndrome‐Associated Colorectal Cancer Offer Insights for Targeted Treatment

    • Authors: May J. Krause, Musalula Sinkala, Raj Ramesar
    • Year: 2025
    • Citation: Krause MJ, Sinkala M, Ramesar R. Distinct Dysregulated Pathways in Sporadic and Lynch Syndrome‐Associated Colorectal Cancer Offer Insights for Targeted Treatment. FEBS Lett. 2025; DOI: 10.1002/1873-3468.70010.

  • Screening of Inherited Retinal Disease Patients in a Low‐Resource Setting Using an Augmented Next‐Generation Sequencing Panel

    • Authors: Nicole Midgley, George Rebello, Lara K. Holtes, Raj Ramesar, Lisa Roberts
    • Year: 2024
    • Citation: Midgley N, Rebello G, Holtes LK, Ramesar R, Roberts L. Screening of Inherited Retinal Disease Patients in a Low‐Resource Setting Using an Augmented Next‐Generation Sequencing Panel. Mol Genet Genomic Med. 2024; DOI: 10.1002/mgg3.70046.

  • Genomic Medicine in the Developing World: Cancer Spectrum, Cumulative Risk and Survival Outcomes for Lynch Syndrome Variant Heterozygotes with Germline Pathogenic Variants in the MLH1 and MSH2 Genes

    • Authors: Lutricia Ndou, Ramadhani Chambuso, Ursula Algar, Adam Boutall, Paul Goldberg, Raj Ramesar
    • Year: 2024
    • Citation: Ndou L, Chambuso R, Algar U, Boutall A, Goldberg P, Ramesar R. Genomic Medicine in the Developing World: Cancer Spectrum, Cumulative Risk and Survival Outcomes for Lynch Syndrome Variant Heterozygotes with Germline Pathogenic Variants in the MLH1 and MSH2 Genes. Biomedicines. 2024;12(12):2906. DOI: 10.3390/biomedicines12122906.

  • Influence of Genetic Polymorphisms on the Age at Cancer Diagnosis in a Homogenous Lynch Syndrome Cohort of Individuals Carrying the MLH1:c.1528C>T South African Founder Variant

    • Authors: Lutricia Ndou, Ramadhani Chambuso, Ursula Algar, Paul Goldberg, Adam Boutall, Raj Ramesar
    • Year: 2024
    • Citation: Ndou L, Chambuso R, Algar U, Goldberg P, Boutall A, Ramesar R. Influence of Genetic Polymorphisms on the Age at Cancer Diagnosis in a Homogenous Lynch Syndrome Cohort of Individuals Carrying the MLH1:c.1528C>T South African Founder Variant. Biomedicines. 2024;12(10):2201. DOI: 10.3390/biomedicines12102201.

  • Human Leukocyte Antigen-Allelic Variations May Influence the Age at Cancer Diagnosis in Lynch Syndrome

    • Authors: Lutricia Ndou, Ramadhani Chambuso, Ziyaad Valley-Omar, George Rebello, Ursula Algar, Paul Goldberg, Adam Boutall, Raj Ramesar
    • Year: 2024
    • Citation: Ndou L, Chambuso R, Valley-Omar Z, Rebello G, Algar U, Goldberg P, Boutall A, Ramesar R. Human Leukocyte Antigen-Allelic Variations May Influence the Age at Cancer Diagnosis in Lynch Syndrome. J Pers Med. 2024;14(6):575. DOI: 10.3390/jpm14060575.

  • Investigating Somatic Variants and Pathways in Mismatch Repair-Deficient (dMMR) Colorectal Carcinoma in South Africa

    • Authors: Aldera AP, van der Westhuizen J, Tsai W, Krause MJ, Yildiz S, Pillay K, Boutall A, Ramesar R
    • Year: 2024
    • Citation: Aldera AP, van der Westhuizen J, Tsai W, Krause MJ, Yildiz S, Pillay K, Boutall A, Ramesar R. Investigating Somatic Variants and Pathways in Mismatch Repair-Deficient (dMMR) Colorectal Carcinoma in South Africa. J Clin Pathol. 2024; DOI: 10.1136/jcp-2024-209526.

  • Towards Uncovering the Role of Incomplete Penetrance in Maculopathies through Sequencing of 105 Disease-Associated Genes

    • Authors: Hitti-Malin RJ, Panneman DM, Corradi Z, Boonen EGM, Astuti G, Dhaenens CM, Stöhr H, Weber BHF, Sharon D, Banin E, Raj Ramesar, et al.
    • Year: 2024
    • Citation: Hitti-Malin RJ, Panneman DM, Corradi Z, Boonen EGM, Astuti G, Dhaenens CM, Stöhr H, Weber BHF, Sharon D, Banin E, Ramesar R, et al. Towards Uncovering the Role of Incomplete Penetrance in Maculopathies through Sequencing of 105 Disease-Associated Genes. Biomolecules. 2024;14(3):367. DOI: 10.3390/biom14030367.

  • Human Leukocyte Antigen-Allelic Variations May Influence the Age at Cancer Diagnosis in Lynch Syndrome

    • Authors: Lutricia Ndou, Ramadhani Chambuso, Ziyaad Valley-Omar, George Rebello, Ursula Algar, Paul Goldberg, Adam Boutall, Raj Ramesar
    • Year: 2024
    • Citation: Ndou L, Chambuso R, Valley-O

Hyun Sook Park | Medicine and Dentistry | Women Researcher Award

Posted on by ScienceFather

Dr. Hyun Sook Park | Medicine and Dentistry | Women Researcher Award

CEO at CEFO, South Korea

Dr. Hyun-Sook Park is an accomplished researcher and leader in the fields of stem cell science, tissue engineering, and regenerative medicine. She holds a Ph.D. in Pathology from Imperial College London, where she focused on adult stem cells in the gastrointestinal tract. As the CEO of CEFO Bio Co., Ltd, Dr. Park has spearheaded innovations in stem cell therapies and bioengineering, with significant contributions to skin regeneration and pancreatic beta-cell differentiation. Her academic career includes roles as an affiliated professor at prestigious Korean universities. Dr. Park has held key leadership positions, including serving on boards for the Korea Society of Stem Cell Research and the Korean Tissue Engineering & Regenerative Medicine. She has received numerous awards, such as the British Council Ph.D. Award and Digital Innovation Award, recognizing her groundbreaking research. Dr. Park is also actively involved in shaping national policy on biomedical sciences and advancing global research initiatives.

Professional Profile

Education

Dr. Hyun-Sook Park has a distinguished academic background, with degrees from prestigious institutions. She earned her Bachelor of Science in Biology from Korea University in Seoul (1982-1986), followed by a Master of Science in Zoology from the same university (1986-1988). Dr. Park then pursued a Ph.D. in Pathology at Imperial College London, where she focused on adult stem cells in the gastrointestinal tract and their role in cancer development and regeneration. She completed her Ph.D. under the supervision of Dr. Nicholas A. Wright in 1997, at the Imperial College School of Medicine. Her research at Imperial College, specifically on gastrointestinal epithelial stem cells, marked the beginning of her long-standing interest in stem cell science. This educational foundation laid the groundwork for her future groundbreaking contributions to stem cell research, tissue engineering, and regenerative medicine, establishing her as a leader in the biomedical field.

Professional Experience

Dr. Hyun-Sook Park has an extensive professional career in biomedical research and leadership. She is the CEO of CEFO Bio Co., Ltd, where she oversees the company’s innovative work in stem cell therapies and bioengineering. Dr. Park’s research experience spans several prestigious institutions. She served as Vice Director at BioSolution (2007-2011), focusing on human embryonic stem cells and skin regeneration. Prior to this, she was Director of the Research Institute at MizMedi Hospital Medical Research Center (2005-2007), where she studied stem cell differentiation. Dr. Park also worked as a Senior Research Scientist at the Institute of Radiological and Medical Sciences (1999-2005), specializing in tissue engineering and pancreatic beta-cell differentiation. She has held postdoctoral roles, including at the Korea Research Institute of Bioscience and Biotechnology, and was a visiting researcher at the Imperial Cancer Research Fund. Her career has also included advisory roles and leadership in scientific committees and organizations.

Research Interests

Dr. Hyun-Sook Park’s research interests are centered around stem cell science, tissue engineering, and regenerative medicine. Her early work focused on adult stem cells in the gastrointestinal tract, exploring their role in cancer development and tissue regeneration. Over the years, she expanded her research to encompass a range of biomedical applications, including human embryonic stem cell differentiation, specifically in endodermal and mesodermal lineages. Dr. Park has made significant contributions to the development of bioartificial tissues, such as skin regeneration, and the differentiation of pancreatic beta cells from stem cells for potential diabetes treatments. Her research also explores gene therapy and the use of stem cells in cancer therapies. More recently, she has been involved in advanced techniques, such as the use of ultra-sensitive nanoparticles for tracking endothelial cells. Dr. Park’s work is crucial in advancing regenerative medicine and tissue engineering, with the potential to revolutionize treatments for various diseases.

Awards and Honors

Dr. Hyun-Sook Park has received numerous prestigious awards and honors throughout her career, recognizing her exceptional contributions to scientific research and innovation. Among her accolades is the British Council Ph.D. Award (1990) for her outstanding academic achievements. She also received the Digital Innovation Award in 2014 and 2017, acknowledging her pioneering work in stem cell research and regenerative medicine. Dr. Park was awarded the Overseas Research Scholarship Award (1990-1993) and the Weston Scholarship in the Royal Postgraduate Medical School (1990-1993), which supported her studies at Imperial College London. In addition to these awards, Dr. Park’s research has been consistently recognized by the scientific community, reflected in her extensive publication record and involvement in high-impact projects. Her leadership in the field is further highlighted by her membership in influential committees and advisory roles, shaping national policies in biomedical research. These honors underscore her significant impact on science and healthcare advancements.

Conclusion

Dr. Hyun-Sook Park is an outstanding candidate for the Women Researcher Award. With her exemplary leadership in bioengineering and stem cell research, she has made tremendous contributions to the scientific community. Her innovations in regenerative medicine and cancer research, along with her leadership in key professional and governmental committees, underline her profound impact on both science and policy. While there are opportunities for her to increase her global visibility and outreach, her achievements clearly demonstrate the caliber of a distinguished researcher deserving of this prestigious award.

Publications Top Noted

  • Evaluation of Safety and Efficacy of Cell Therapy Based on Osteoblasts Derived from Umbilical Cord Mesenchymal Stem Cells for Osteonecrosis of the Femoral Head: Study Protocol for a Single-Center, Open-Label, Phase I Clinical Trial
    • Authors: Baek, S.-H., Shim, B.-J., Won, H., Park, H.S., Kim, S.-Y.
    • Year: 2024
    • Citations: 0
  • Early Osteogenic-Induced Adipose-Derived Stem Cells and Canine Bone Regeneration Potential Analyzed Using Biodegradable Scaffolds
    • Authors: Yun, H.-H., Kim, S.-G., Park, S.-I., Hong, I.-H., Jeong, K.-S.
    • Year: 2023
    • Citations: 2
  • In Vitro Tracking of Human Umbilical Vein Endothelial Cells Using Ultra-Sensitive Quantum Dot-Embedded Silica Nanoparticles
    • Authors: Kim, J., Lee, S., Lee, Y.K., Jun, B.-H., Park, H.-S.
    • Year: 2023
    • Citations: 6
  • Comparison of Temperature Equilibrium Rate and Cell Growth/Viability Under Air Circulation in Cryogenic Storage Container
    • Authors: Park, J.-Y., Lee, D.-W., Lee, S., Park, H.-S., Yoon, G.-S.
    • Year: 2022
    • Citations: 0
  • Medroxyprogesterone Reverses Tolerable Dose Metformin-Induced Inhibition of Invasion via Matrix Metallopeptidase-9 and Transforming Growth Factor-β1 in KLE Endometrial Cancer Cells
    • Authors: Suh, D.H., Lee, S., Park, H.-S., Park, N.H.
    • Year: 2020
    • Citations: 4
  • Differentiation of Equine Induced Pluripotent Stem Cells into Mesenchymal Lineage for Therapeutic Use
    • Authors: Chung, M.-J., Park, S., Son, J.-Y., Park, H.-S., Jeong, K.-S.
    • Year: 2019
    • Citations: 19
  • Establishment of Stably Expandable Induced Myogenic Stem Cells by Four Transcription Factors
    • Authors: Lee, E.-J., Kim, M., Kim, Y.D., Hwang, D., Jeong, K.-S.
    • Year: 2018
    • Citations: 15
  • Recurrent Variations in DNA Methylation in Human Pluripotent Stem Cells and Their Differentiated Derivatives
    • Authors: Nazor, K.L., Altun, G., Lynch, C., Loring, J.F., Laurent, L.C.
    • Year: 2012
    • Citations: 316
  • The Effects of the Physical Properties of Culture Substrates on the Growth and Differentiation of Human Embryonic Stem Cells
    • Authors: Lee, S., Kim, J., Park, T.J., Kang, S., Park, H.-S.
    • Year: 2011
    • Citations: 29
  • Comparison of Mesenchymal-like Stem/Progenitor Cells Derived from Supernumerary Teeth with Stem Cells from Human Exfoliated Deciduous Teeth
    • Authors: Lee, S., An, S., Kang, T.H., Kwak, C.K., Park, H.-S.
    • Year: 2011
    • Citations: 29

Pengyi Liu | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Pengyi Liu | Medicine and Dentistry | Best Researcher Award

Doctoral student at Shanghai Ruijin Hospital, China

Dr. Pengyi Liu is a dedicated researcher specializing in the tumor immune microenvironment of pancreatic cancer. Currently pursuing a doctoral degree at Ruijin Hospital, Shanghai Jiaotong University, Liu’s work focuses on understanding the roles of macrophages and T cells in tumor progression. With a Bachelor’s degree in Clinical Medicine, Liu has consistently excelled academically, earning numerous honors, including multiple scholarships and recognition as an “Outstanding Graduate.” Their research has led to significant publications in high-impact journals, exploring novel mechanisms in pancreatic cancer, such as macrophage differentiation and immune response modulation. Proficient in various experimental techniques like cell culture, flow cytometry, and molecular biology, Liu demonstrates a broad skill set essential for cutting-edge cancer research. Their collaborative efforts and innovative approaches continue to advance the field, offering potential new targets for diagnosis and treatment. Liu’s work holds promise for improving clinical outcomes in pancreatic cancer patients.

Professional Profile

Education

Dr. Pengyi Liu’s educational journey reflects a strong foundation in clinical medicine and research. He completed his Bachelor’s degree in Clinical Medicine at Shanghai Jiaotong University from 2016 to 2021, achieving a commendable GPA of 3.63. During this time, Liu was recognized for his academic excellence, earning multiple scholarships and being named a “Merit Student” in 2020. After completing his undergraduate studies, Liu continued his education at Ruijin Hospital, affiliated with Shanghai Jiaotong University School of Medicine, where he is currently pursuing a Doctor of Surgery degree under the prestigious “Zhiyuan Honors Program.” His research is guided by Prof. Baiyong Shen, focusing on the molecular mechanisms of pancreatic cancer. In addition to his rigorous academic training, Liu has taken a wide range of courses, including Anatomy, Physiology, Molecular Biology, Immunology, and Laboratory Animal Science, providing him with a well-rounded knowledge base for his advanced research.

Professional Experience

Dr. Pengyi Liu’s professional experience is centered around groundbreaking research in the field of pancreatic cancer. Currently a doctoral candidate at Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Liu is engaged in advanced research on the tumor immune microenvironment, particularly the roles of macrophages and T cells in tumor progression. Under the mentorship of Prof. Baiyong Shen, Liu has contributed to numerous high-impact publications on pancreatic cancer, including studies on macrophage differentiation, immune modulation, and tumor progression. His research projects are multifaceted, encompassing both molecular and animal model-based approaches to uncover novel mechanisms and potential therapeutic targets. Liu is proficient in various laboratory techniques, including cell culture, flow cytometry, molecular biology assays, and the construction of patient-derived xenograft and organoid models. His work continues to shape the understanding of pancreatic cancer, offering new insights into its diagnosis, treatment, and the development of targeted therapies.

Research Interests

Dr. Pengyi Liu’s research interests are centered around the tumor immune microenvironment, with a particular focus on pancreatic cancer. His work aims to understand the complex interactions between immune cells, such as macrophages and T cells, and tumor progression. Liu is dedicated to uncovering the molecular mechanisms that drive pancreatic cancer, especially how immune cells contribute to the tumor environment and influence cancer growth. His research explores the roles of various molecules, including lncRNAs and signaling pathways, in shaping the immune response and tumor microenvironment. By studying the molecular and cellular processes in pancreatic cancer, Liu aims to identify potential therapeutic targets for better diagnosis and treatment strategies. Additionally, Liu’s work involves the development and use of advanced experimental models, such as patient-derived xenografts and organoids, to simulate the tumor environment and test new treatment approaches. His goal is to bridge the gap between basic research and clinical application in oncology.

Awards and Honors

Dr. Pengyi Liu has received numerous awards and honors throughout his academic career, reflecting his exceptional performance and dedication to research. He was awarded the prestigious scholarships of Shanghai Jiaotong University in 2017, 2018, 2019, and 2020, which recognize his academic excellence. In 2020, he was named a “Merit Student,” further highlighting his outstanding achievements. Dr. Liu’s dedication to his studies was also acknowledged when he was recognized as an “Outstanding Graduate” in 2021, a testament to his strong academic record and research contributions. Additionally, as a graduate student, he was awarded the First-Class Scholarship in 2022 and the Second-Class Scholarship in 2023, underscoring his continued academic excellence and research productivity. These accolades demonstrate not only his commitment to excellence but also the recognition he has earned from his peers and academic community for his hard work and significant contributions to the field of medical research.

Conclusion

Pengyi Liu’s academic achievements, extensive research experience, and significant contributions to understanding the tumor immune microenvironment in pancreatic cancer make them a strong contender for the Best Researcher Award. With a clear focus on advancing scientific knowledge and potential for real-world impact, Liu exemplifies the qualities of a leading researcher. Continued diversification of their research scope and greater emphasis on clinical applications could further amplify their contributions to the field.

Publications Top Noted

  1. Comprehensive analysis of KLF family reveals KLF6 as a promising prognostic and immune biomarker in pancreatic ductal adenocarcinoma
    • Authors: Lin, J., Liu, P., Sun, K., Wang, T., Shen, B.
    • Year: 2024
    • Journal: Cancer Cell International
    • Citations: 0
  2. Pan-cancer analysis implicates novel insights of lactate metabolism into immunotherapy response prediction and survival prognostication
    • Authors: Chen, D., Liu, P., Lu, X., Li, H., Shen, B.
    • Year: 2024
    • Journal: Journal of Experimental and Clinical Cancer Research
    • Citations: 0
  3. ATF3-induced activation of NF-κB pathway results in acquired PARP inhibitor resistance in pancreatic adenocarcinoma
    • Authors: Liu, Y., Cao, Y., Liu, P., Wang, W., Shen, B.
    • Year: 2024
    • Journal: Cellular Oncology
    • Citations: 2
  4. BHLHE40 Inhibits Ferroptosis in Pancreatic Cancer Cells via Upregulating SREBF1
    • Authors: Cao, Y., Wang, X., Liu, Y., Jiang, L., Shen, B.
    • Year: 2024
    • Journal: Advanced Science
    • Citations: 3
  5. CTCF enhances pancreatic cancer progression via FLG-AS1-dependent epigenetic regulation and macrophage polarization
    • Authors: Liu, Y., Liu, P., Duan, S., Jiang, Y., Shen, B.
    • Year: 2024
    • Journal: Cell Death and Differentiation
    • Citations: 0
  6. SNHG17 alters anaerobic glycolysis by resetting phosphorylation modification of PGK1 to foster pro-tumor macrophage formation in pancreatic ductal adenocarcinoma
    • Authors: Lin, J., Liu, Y., Liu, P., Bao, H., Lin, J.
    • Year: 2023
    • Journal: Journal of Experimental and Clinical Cancer Research
    • Citations: 0
  7. A microprotein N1DARP encoded by LINC00261 promotes Notch1 intracellular domain (N1ICD) degradation via disrupting USP10-N1ICD interaction to inhibit chemoresistance in Notch1-hyperactivated pancreatic cancer
    • Authors: Zhai, S., Lin, J., Ji, Y., Deng, X., Shen, B.
    • Year: 2023
    • Journal: Cell Discovery
    • Citations: 10
  8. Single-cell RNA-seq analysis reveals BHLHE40-driven pro-tumour neutrophils with hyperactivated glycolysis in pancreatic tumour microenvironment
    • Authors: Wang, L., Liu, Y., Dai, Y., Chen, S., Shen, B.
    • Year: 2023
    • Journal: Gut
    • Citations: 100
  9. LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma
    • Authors: Liu, Y., Shi, M., He, X., Sun, B., Shen, B.
    • Year: 2022
    • Journal: Journal of Hematology and Oncology
    • Citations: 76

Tingting Gao | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Tingting Gao | Medicine and Dentistry | Best Researcher Award

Doctor at Shanxi medical university, China

Dr. Tingting Gao is a dedicated and accomplished medical researcher with a strong focus on vascular surgery, immunometabolomics, and multimodal molecular imaging. She is currently pursuing her Doctor of Medicine and Master of Medicine at Shanxi Medical University, where she works under the guidance of Professor Honglin Dong. With a broad range of research interests and expertise in cutting-edge imaging technologies, Dr. Gao has made significant contributions to the understanding of vascular diseases, atherosclerosis, and kidney injury. Her work bridges the gap between experimental biology and clinical applications, demonstrating a commitment to advancing both basic and translational research.

Professional Profile

Education

Dr. Tingting Gao is currently completing her Doctor of Medicine and Master of Medicine at Shanxi Medical University, Taiyuan, China. She has been under the academic mentorship of Dr. Honglin Dong, MD, Ph.D., Assistant Dean of The Second Hospital of Shanxi Medical University. Her education has provided her with a strong foundation in both medical practice and research, allowing her to contribute to the field of vascular surgery while pursuing advanced studies in molecular medicine and disease mechanisms. Her educational journey emphasizes her dedication to both scientific inquiry and clinical expertise.

Professional Experience

Dr. Gao’s professional experience includes significant roles as a Research Assistant in the Department of Vascular Surgery at The Second Hospital of Shanxi Medical University, where she has worked from 2023 to the present. In this role, she conducts research focused on immunometabolomics and multimodal molecular imaging of vascular diseases. She has also worked as a subject participant in various research projects, such as the study of aortic aneurysms and contrast-induced acute kidney injury. Additionally, Dr. Gao has extensive clinical experience in vascular surgery, having worked from 2018 to 2022 in the same hospital, gaining hands-on expertise in patient care and surgical procedures.

Research Interests

Dr. Gao’s research interests span several domains, including vascular surgery, atherosclerosis, liver disease, and imaging technologies. She is particularly interested in the mechanisms underlying vascular diseases, such as atherosclerosis, and how substances like garlic can impact these conditions. Her work integrates network pharmacology, bioinformatics, and experimental verification to explore therapeutic pathways like ferroptosis. Additionally, she focuses on advanced imaging techniques, such as photoacoustic microscopy and magnetic nanoparticle imaging, to better understand disease mechanisms and improve diagnostic tools. Her multidisciplinary approach blends laboratory research with clinical applications, aiming to make a significant impact in both fields.

Awards and Honors

Dr. Gao has received recognition for her research contributions through various awards and honors. She has been a part of multiple funded projects, including those by the Shanxi Provincial Science and Technology Department and the Scientific and Technological Innovation Programs of Higher Education Institutions in Shanxi Province. These grants have supported her participation in cutting-edge research exploring vascular diseases, kidney injury, and novel imaging technologies. Dr. Gao’s dedication to her field has also been acknowledged by her peers, reflected in her impressive publication record and active participation in international conferences, where she has presented her findings at major forums like the World Molecular Imaging Society.

Conclusion

The individual appears highly deserving of the Best Researcher Award due to their comprehensive academic background, impressive publication record, technical expertise, and contributions to advanced research in vascular diseases, imaging technologies, and pharmacology. They have demonstrated creativity and leadership in scientific exploration, with innovative work that holds significant potential for clinical applications. However, future opportunities for growth could include assuming more independent leadership roles, increasing international recognition, and further advancing the clinical impact of their research.

Publications Top Noted

  1. Title: Highly sensitive magnetic particle imaging of abdominal aortic aneurysm NETosis with anti-Ly6G iron oxide nanoparticles
    Authors: Wang, H., Zhang, R., Jia, X., Hui, H., Dong, H.
    Year: 2024
    Citations: 0
  2. Title: Exploring the therapeutic potential of garlic in alcoholic liver disease: a network pharmacology and experimental validation study
    Authors: Gao, S., Gao, T., Li, L., Zhou, Y., Dong, H.
    Year: 2024
    Citations: 0
  3. Title: Nobiletin alleviates atherosclerosis by inhibiting lipid uptake via the PPARG/CD36 pathway
    Authors: Wang, H., Tian, Q., Zhang, R., Zheng, G., Dong, H.
    Year: 2024
    Citations: 2
  4. Title: The Protective Role of Intermedin in Contrast-Induced Acute Kidney Injury: Enhancing Peritubular Capillary Endothelial Cell Adhesion and Integrity Through the cAMP/Rac1 Pathway
    Authors: Gao, T., Gu, R., Wang, H., Zheng, G., Dong, H.
    Year: 2024
    Citations: 0
  5. Title: The Down-Shifting Luminescence of Rare-Earth Nanoparticles for Multimodal Imaging and Photothermal Therapy of Breast Cancer
    Authors: Gao, T., Gao, S., Li, Y., Zhang, R., Dong, H.
    Year: 2024
    Citations: 0
  6. Title: Case Report: The application of novel imaging technologies in lower extremity peripheral artery disease: NIR-II imaging, OCTA, and LSFG
    Authors: Ning, Y., Hu, J., Li, H., Zhang, R., Dong, H.
    Year: 2024
    Citations: 0
  7. Title: Garlic ameliorates atherosclerosis by regulating ferroptosis pathway: an integrated strategy of network pharmacology, bioinformatic and experimental verification
    Authors: Gao, T., Gao, S., Wang, H., Zhou, Y., Dong, H.
    Year: 2024
    Citations: 0
  8. Title: Metabolomics and network pharmacology exploration of the effects of bile acids on carotid atherosclerosis and potential underlying mechanisms
    Authors: Cheng, X., Zhang, R., Qi, X., Zheng, G., Dong, H.
    Year: 2024
    Citations: 0
  9. Title: High estrogen induces trans-differentiation of vascular smooth muscle cells to a macrophage-like phenotype resulting in aortic inflammation via inhibiting VHL/HIF1a/KLF4 axis
    Authors: Zhang, R., Wang, H., Cheng, X., Zheng, G., Dong, H.
    Year: 2024
    Citations: 0
  10. Title: Neutrophil Extracellular Traps Aggravate Contrast-Induced Acute Kidney Injury by Damaging Glomeruli and Peritubular Capillaries
    Authors: Wang, H., Gao, T., Zhang, R., Zheng, G., Dong, H.
    Year: 2023
    Citations: 5

Guoping Zheng | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Assoc. Prof. Dr. Guoping Zheng | Medicine and Dentistry | Best Researcher Award

Laboratory head at University of Sydney (WIMR), Australia

Associate Professor Guoping Zheng is a renowned researcher and academic in the field of medicine, specializing in kidney injury, repair, and fibrosis. He is currently an Associate Professor at the University of Sydney, within the Faculty of Medicine and Health, and holds a prestigious NHMRC Principal Research Fellowship at the Westmead Institute for Medical Research. Dr. Zheng has led pioneering research projects in kidney transplantation, fibrosis, and inflammatory diseases, contributing significantly to our understanding of kidney pathophysiology and potential therapeutic interventions. With a research portfolio that spans over two decades, Dr. Zheng has garnered international recognition for his innovative work in renal medicine, including developing engineered macrophages for treating chronic kidney disease. His research impact is further demonstrated by his high citation index, editorial roles in top journals, and his numerous academic and institutional leadership positions.

Professional Profile

Education

Dr. Guoping Zheng has an impressive educational background in medical and molecular sciences. He earned his PhD from the University of Sydney’s Faculty of Medicine, where he conducted research from 1998 to 2002. Before that, he completed a Master of Medicine by research at Shanxi Medical University in China, specializing in biochemistry and molecular biology from 1985 to 1988. Dr. Zheng also holds an MBBS degree from the same institution, completed in 1985. His educational journey laid a strong foundation for his future research and teaching career, enabling him to contribute extensively to the understanding of kidney disease, renal fibrosis, and related inflammatory processes.

Professional Experience

Dr. Zheng has held a distinguished academic career, with extensive roles at the University of Sydney and the Westmead Institute for Medical Research (WIMR). Since 2003, he has been a key figure at the Centre for Transplantation and Renal Research, where he currently serves as an Associate Professor and leads the Kidney Injury Repair and Fibrosis Study Group. His prior roles include Senior Research Officer and Research Officer, with a focus on kidney pathology. Dr. Zheng has also been an NHMRC Peter Doherty Fellow and a lecturer at the University of Sydney. His professional trajectory reflects a deep commitment to advancing medical research and education, particularly in the field of nephrology and renal transplantation. Additionally, Dr. Zheng has held several executive committee positions at WIMR and serves as a mentor and reviewer for multiple research bodies and academic institutions globally.

Research Interests

Dr. Zheng’s research focuses on kidney injury, repair mechanisms, and fibrosis, particularly in the context of chronic kidney disease and renal transplantation. His work aims to uncover novel therapeutic strategies for kidney fibrosis, a key driver of kidney failure. Dr. Zheng has explored several molecular pathways, including the role of macrophages, TGF-β signaling, and matrix metalloproteinases in fibrosis and inflammation. His research also investigates the potential of engineered cells, such as chimeric antigen receptor macrophages, to prevent kidney damage. Another significant area of interest includes the differentiation of pro-fibrotic from anti-inflammatory effects of TGF-β in kidney fibrosis, which may lead to more effective treatments for renal diseases. Dr. Zheng’s interdisciplinary approach bridges biochemistry, molecular biology, and clinical medicine, advancing both basic science and therapeutic innovation in renal health.

Awards and Honors

Dr. Zheng has received numerous awards and honors throughout his distinguished career, recognizing his outstanding contributions to medical research. He has been awarded the prestigious Westmead Millennium Institute Science Prize five times (2006, 2010, 2013, 2017, and 2021), which is granted to the best original research within his institution. Additionally, he was a finalist for the Basic Science Award at both the 55th ANZSN Annual Scientific Meeting (2020) and the 5th Asian Pacific Congress of Nephrology (2016). Dr. Zheng has also received various recognitions for his poster presentations and research symposia, including multiple “Best Poster Presentation Prizes” at the Annual Research Symposium during Hospital Week. These honors reflect his ongoing dedication to advancing scientific understanding in nephrology and transplantation. Moreover, he has been recognized internationally with travel awards and fellowships, including the New Investigator Travel Award for the Pan-Pacific Connective Tissue Societies Symposium in 1999.

Conclusion

Associate Professor Guoping Zheng stands as a highly suitable candidate for the Best Researcher Award. His extensive research experience, influential publications, multiple awards, and leadership in renal medicine demonstrate a strong commitment to advancing medical knowledge and treatment options for kidney disease. Areas of further development, such as advancing his work’s clinical translation and expanding international collaborations, could add even more depth to his already impressive career. Overall, Dr. Zheng’s accomplishments, recognized expertise, and continuous contributions make him a deserving candidate for this prestigious recognition.

Publications Top Noted

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)
    • Authors: DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, …
    • Year: 2021
    • Citations: 10,941
  2. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
    • Authors: DJ Klionsky, H Abeliovich, P Agostinis, DK Agrawal, G Aliev, DS Askew, …
    • Year: 2008
    • Citations: 2,962
  3. E‐Cadherin/β‐Catenin Complex and the Epithelial Barrier
    • Authors: X Tian, Z Liu, B Niu, J Zhang, TK Tan, SR Lee, Y Zhao, DCH Harris, …
    • Year: 2011
    • Citations: 610
  4. Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease
    • Authors: Y Wang, YP Wang, G Zheng, VWS Lee, L Ouyang, DHH Chang, …
    • Year: 2007
    • Citations: 449
  5. IL-10/TGF-β–modified macrophages induce regulatory T cells and protect against adriamycin nephrosis
    • Authors: Q Cao, Y Wang, D Zheng, Y Sun, Y Wang, VWS Lee, G Zheng, TK Tan, …
    • Year: 2010
    • Citations: 319
  6. Disruption of E-cadherin by matrix metalloproteinase directly mediates epithelial-mesenchymal transition downstream of transforming growth factor-β1 in renal tubular epithelial …
    • Authors: G Zheng, JG Lyons, TK Tan, Y Wang, TT Hsu, D Min, L Succar, …
    • Year: 2009
    • Citations: 286
  7. Characterization of murine macrophages from bone marrow, spleen and peritoneum
    • Authors: C Wang, X Yu, Q Cao, Y Wang, G Zheng, TK Tan, H Zhao, Y Zhao, …
    • Year: 2013
    • Citations: 273
  8. Discrete functions of M2a and M2c macrophage subsets determine their relative efficacy in treating chronic kidney disease
    • Authors: J Lu, QI Cao, D Zheng, Y Sun, C Wang, X Yu, YA Wang, VWS Lee, …
    • Year: 2013
    • Citations: 254
  9. Macrophage matrix metalloproteinase-9 mediates epithelial-mesenchymal transition in vitro in murine renal tubular cells
    • Authors: TK Tan, G Zheng, TT Hsu, Y Wang, VWS Lee, X Tian, Y Wang, Q Cao, …
    • Year: 2010
    • Citations: 185
  10. Matrix metalloproteinases contribute to kidney fibrosis in chronic kidney diseases
    • Authors: H Zhao, Y Dong, X Tian, TK Tan, Z Liu, Y Zhao, Y Zhang, DCH Harris, …
    • Year: 2013
    • Citations: 177
  11. Matrix metalloproteinase-9 of tubular and macrophage origin contributes to the pathogenesis of renal fibrosis via macrophage recruitment through osteopontin cleavage
    • Authors: T Kui Tan, G Zheng, TT Hsu, S Ra Lee, J Zhang, Y Zhao, X Tian, Y Wang, …
    • Year: 2013
    • Citations: 175
  12. CD4+ CD25+ regulatory T cells protect against injury in an innate murine model of chronic kidney disease
    • Authors: D Mahajan, Y Wang, X Qin, Y Wang, G Zheng, YM Wang, SI Alexander, …
    • Year: 2006
    • Citations: 173
  13. Potentiating tissue-resident type 2 innate lymphoid cells by IL-33 to prevent renal ischemia-reperfusion injury
    • Authors: Q Cao, Y Wang, Z Niu, C Wang, R Wang, Z Zhang, T Chen, XM Wang, …
    • Year: 2018
    • Citations: 114
  14. Renal F4/80+ CD11c+ mononuclear phagocytes display phenotypic and functional characteristics of macrophages in health and in adriamycin nephropathy
    • Authors: Q Cao, Y Wang, XM Wang, J Lu, VWS Lee, Q Ye, H Nguyen, G Zheng, …
    • Year: 2015
    • Citations: 112
  15. Transfused macrophages ameliorate pancreatic and renal injury in murine diabetes mellitus
    • Authors: D Zheng, Y Wang, Q Cao, VWS Lee, G Zheng, Y Sun, TK Tan, Y Wang, …
    • Year: 2011
    • Citations: 100

Napoliane Santos | Medicine and Dentistry | Women Researcher Award

Posted on by ScienceFather

Mrs. Napoliane Santos | Medicine and Dentistry | Women Researcher Award

Medica at Intituto brasileiro de medicina regenerativa, Brazil

Dr. Napoliane Costa Santos is a skilled radiologist and ultrasonography specialist with extensive experience in patient-focused diagnostic imaging. Driven by a commitment to provide compassionate care, she combines her technical expertise with a mission to ensure that patients feel comfortable and well-supported during their medical exams. Her career spans over a decade, during which she has contributed significantly to multiple healthcare institutions, specializing in general ultrasonography, pain intervention, and regenerative medicine. Her dedication to patient care and her proactive approach in advanced medical imaging make her a standout professional in her field. Additionally, she is deeply involved in medical education, where she shares her expertise with emerging healthcare professionals, furthering the field of ultrasonography and enhancing patient outcomes through her leadership.

Professional Profile

Education

Dr. Santos has a well-rounded educational background, beginning with her medical degree from the Universidade do Estado do Pará in 2012. Following this, she completed a medical residency at Hospital Maternidade Frei Galvão, a program accredited by the Brazilian College of Radiology. Her formal education continued with specialized certifications, including a Diagnostic Imaging specialization in General Ultrasonography, recognized by a national board in 2018. More recently, she pursued postgraduate studies in pain intervention and regenerative medicine at Orthoregen, Brazil, enhancing her expertise in minimally invasive techniques for pain relief. Other certifications include postgraduate work in musculoskeletal imaging, thermography, and clinical pain, showing her continuous pursuit of knowledge and advanced skills in radiology and ultrasonography.

Professional Experience

Dr. Santos’s career is marked by her longstanding roles in numerous reputable healthcare settings. Since 2013, she has been an ultrasonography specialist at Hospital Maternidade Frei Galvão in Guaratinguetá, where she performs general ultrasound exams. Her expertise in pain intervention led her to positions at Clínica Moverti and Hospital Policlin in São Paulo, where she has practiced since 2019 and 2017, respectively. Additionally, she contributes to the BIRM Instituto Brasileiro de Medicina Regenerativa and Orthoregen, focusing on clinical research, pain intervention, and regenerative medicine. At Orthoregen, she also serves as an instructor, training other healthcare providers in advanced ultrasonography techniques, further broadening her impact within the field.

Research Interests

Dr. Santos’s research interests are centered on the applications of diagnostic imaging in managing chronic pain and regenerative medicine. Her focus on ultrasonography-guided, minimally invasive pain treatments addresses a significant area in modern healthcare, particularly for patients with musculoskeletal disorders. She is especially interested in exploring how advancements in ultrasonography can enhance patient outcomes in musculoskeletal and rheumatologic conditions. Her work at Orthoregen and BIRM reflects her dedication to integrating clinical research with practical applications, aiming to advance the fields of pain intervention and regenerative medicine. Through ongoing studies and clinical practices, she continues to contribute to research that seeks innovative, non-invasive solutions for chronic pain.

Awards and Honors

While Dr. Santos has yet to receive major publicized awards, her growing expertise and roles in esteemed institutions highlight her accomplishments. Her board certification as a Diagnostic Imaging Specialist by the Brazilian College of Radiology reflects a high level of professional recognition. Her responsibilities as an instructor in ultrasonography and pain intervention signify trust in her abilities to lead and mentor, which is a significant professional honor. As her clinical and research contributions gain visibility, Dr. Santos stands poised for recognition in healthcare and research awards, particularly those honoring advancements in diagnostic radiology and compassionate patient care. Her dedication to her field is evident, positioning her as a respected professional and potential candidate for future honors.

Conclusion

Napoliane Costa Santos possesses a strong foundation for the Women Researcher Award due to her depth of clinical expertise, specialized training in ultrasonography and pain management, and commitment to patient care. She demonstrates both technical skill and compassionate care, essential qualities in healthcare research and practice. However, to strengthen her candidacy, a greater focus on documented research contributions, leadership in scientific projects, and published innovations would be advantageous. Overall, she is a promising candidate with potential to make a meaningful impact through further academic and research pursuits in her field.

Publications Top Noted

  1. SDIMMMER: A Proposed Clinical Approach to Optimize Cellular Physiology in Regenerative Medicine
    • Authors: Lana, J.V., Lana, J.F., Melo, G., Pires, L., Tambeli, C.H.
    • Year: 2024
    • Citation Count: 0
  2. Regenerative Inflammation: The Mechanism Explained from the Perspective of Buffy-Coat Protagonism and Macrophage Polarization
    • Authors: Martins, R.A., Costa, F.R., Pires, L., Kruel, A., Lana, J.F.
    • Year: 2024
    • Citation Count: 0
  3. Nebulized Glutathione as a Key Antioxidant for the Treatment of Oxidative Stress in Neurodegenerative Conditions
    • Authors: Lana, J.V., Rios, A., Takeyama, R., Purita, J., Lana, J.F.
    • Year: 2024
    • Citation Count: 3
  4. The Biological Role of Platelet Derivatives in Regenerative Aesthetics
    • Authors: Santos, L.C., Lana, G.L., Santos, G.S., Tambeli, C.H., Lana, J.F.
    • Year: 2024
    • Citation Count: 4
  5. Sacral Bioneuromodulation: The Role of Bone Marrow Aspirate in Spinal Cord Injuries
    • Authors: Lana, J.F., Navani, A., Jeyaraman, M., de Moraes Ferreira Jorge, D., Purita, J.
    • Year: 2024
    • Citation Count: 0
  6. The Role of Orthobiologics in Chronic Wound Healing
    • Authors: Domingues, R.B., von Rautenfeld, M., Kavalco, C.M., Everts, P., Lana, J.F.
    • Year: 2024
    • Citation Count: 4

Olgica Mihaljevic | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Prof. Olgica Mihaljevic | Medicine and Dentistry | Best Researcher Award

Prof at University of Kragujevac, Serbia, Faculty of Medical sciences, Department of Pathophysiology, Serbia

Prof. Olgica Mihaljevic, a distinguished medical researcher and educator, specializes in pathophysiology with a focus on internal medicine, carcinoma, thyroid diseases, and public health. She earned her PhD with a thesis on apoptosis and oxidative stress in thyroid carcinoma patients, showcasing her expertise in cellular mechanisms related to cancer. With over 15 years of experience, Mihaljevic has held various academic positions, including her current role as head of the pathophysiology department, and teaches at the Military Medical Academy in Belgrade. Her research contributions are extensive, addressing critical health issues like COVID-19, cancer screening, and healthcare disparities. A committed member of professional bodies, she is vice president of the Pathophysiology Section of the Serbian Medical Association. Mihaljevic’s work in high-impact areas and dedication to medical education and public health make her a highly respected figure in Serbia’s medical community and a strong candidate for research accolades.

Professional Profile

Education

Prof. Olgica Mihaljevic completed her medical education at the Faculty of Medical Sciences, University of Kragujevac, where she earned her medical degree in 2007 with an impressive average grade of 9.83. Following her undergraduate studies, she pursued postgraduate education in Clinical and Experimental Internal Medicine at the same institution, achieving an average grade of 9.0. In 2014, she completed her PhD with a thesis focused on the changes in apoptosis of lymphocytes, oxidative stress parameters, and cytokine profiles in patients with differentiated thyroid carcinoma. This research highlighted her expertise in understanding the molecular and biochemical mechanisms behind thyroid diseases and cancer. Her academic journey has been marked by excellence, reflected in both her grades and the depth of her research in critical areas of internal medicine, oncology, and public health. Prof. Mihaljevic’s strong educational background laid the foundation for her successful academic and professional career.

Professional Experience

Prof. Olgica Mihaljevic has over 15 years of professional experience in both research and education. She began her academic career in 2008 as a teaching assistant in the Department of Pathophysiology at the Faculty of Medical Sciences, University of Kragujevac, where she progressed to assistant and later assistant professor by 2016. During this time, she contributed to the education of medical students and the development of curriculum in pathophysiology. In 2017, she became the head of the Department of Pathophysiology in basic dental studies and later took on a role as a lecturer at the Military Medical Academy in Belgrade. In 2023, she was appointed head of the Department of Pathophysiology for basic medical studies in English at the University of Kragujevac. In addition to her academic roles, Mihaljevic is actively involved in medical research, publishing extensively on topics such as cancer, oxidative stress, and public health.

Research Interests

Prof. Olgica Mihaljevic’s research interests span several critical areas of medicine, with a strong focus on internal medicine, dermatology, and oncology. Her work primarily investigates the pathophysiology of thyroid gland diseases, particularly thyroid carcinoma, where she explores cellular mechanisms like apoptosis, oxidative stress, and cytokine profiles. Additionally, she studies the molecular aspects of autoimmune diseases, nephrology, and radiotherapy. Mihaljevic has a keen interest in the role of genome damage in disease progression, especially in cancer. She is also committed to understanding the broader impacts of public health, focusing on the sociodemographic factors influencing cancer screenings and healthcare access. Her research aims to bridge the gap between clinical practices and molecular biology, improving patient care and disease management. Prof. Mihaljevic’s contributions are especially relevant in addressing major health challenges like cancer, autoimmune disorders, and the effects of oxidative stress, making her research crucial to both medical science and public health.

Awards and Honors

Prof. Olgica Mihaljevic has earned numerous accolades throughout her career, reflecting her dedication to research and education in the medical field. As a highly respected academic, she has been recognized for her contributions to pathophysiology and public health. Prof. Mihaljevic holds several key leadership roles in professional medical organizations, including being a vice president of the Pathophysiology Section of the Serbian Medical Association. She is also an active member of the Serbian Medical Society and the Medical Chamber of Serbia. Her commitment to advancing medical science is evident in her editorial role on the Medical Journal of the Serbian Medical Society, where she contributes to the dissemination of critical research. Through her research, especially in cancer, oxidative stress, and healthcare disparities, Prof. Mihaljevic has garnered recognition from both national and international medical communities. Her academic and research achievements solidify her reputation as a leader in her field.

Conclusion

Olgica Mihaljevic is a highly qualified candidate for the Best Researcher Award, given her extensive expertise, research contributions, and leadership in medical sciences. Her focus on significant health issues like carcinoma, oxidative stress, and public health aligns well with the award’s purpose of recognizing impactful medical research. With strategic enhancements in international collaboration and funding acquisition, she could further amplify her contributions to the field. Overall, Mihaljevic demonstrates the attributes and achievements that make her a worthy candidate for this awar

Publications Top Noted

  • Title: Laboratory Puzzle of Oxidative Stress, Parameters of Hemostasis and Inflammation in Hospitalized Patients with COVID-19
    Authors: Djordjevic, J., Ignjatovic, V., Vukomanovic, V., Stanojevic Pirkovic, M., Mihaljevic, O.
    Journal: Biomedicines
    Year: 2024
    Volume: 12(3), 636
    Citations: 1
  • Title: Socioeconomic and Health Characteristics as Predictors of Social Support in Elderly People with Visual Impairment: Evidence from Serbia
    Authors: Djurovic, N., Radovanovic, S., Mihaljevic, O., Vasiljevic, D., Selakovic, V.
    Journal: Iranian Journal of Public Health
    Year: 2024
    Volume: 53(10), 2251-2259
    Citations: 0
  • Title: Sociodemographic Factors Associated with Breast Cancer Screening Among Women in Serbia, National Health Survey
    Authors: Djordjević, S., Dimitrijev, I., Boričić, K., Sorak, M., Jovanović, V.
    Journal: Iranian Journal of Public Health
    Year: 2024
    Volume: 53(2), 387–396
    Citations: 0
  • Title: Transforming Growth Factor Beta 1 (TGF-β1) in COVID-19 Patients: Relation to Platelets and Association with the Disease Outcome
    Authors: Zivancevic-Simonovic, S., Minic, R., Cupurdija, V., Jakovljevic, V., Mihaljevic, O.
    Journal: Molecular and Cellular Biochemistry
    Year: 2023
    Volume: 478(11), 2461–2471
    Citations: 6
  • Title: Oxidative Stress and DNA Damage in Critically Ill Patients with Sepsis
    Authors: Mihaljevic, O., Zivancevic-Simonovic, S., Jovanovic, D., Jakovljevic, V., Milosevic-Djordjevic, O.
    Journal: Mutation Research – Genetic Toxicology and Environmental Mutagenesis
    Year: 2023
    Volume: 889, 503655
    Citations: 2
  • Title: Effect of the COVID-19 Pandemic on Surgery for Indeterminate Thyroid Nodules (THYCOVID): A Retrospective, International, Multicenter, Cross-sectional Study
    Authors: Medas, F., Dobrinja, C., Al-Suhaimi, E.A., Zahid, M.T., Zielke, A., Mihaljevic, O.
    Journal: The Lancet Diabetes and Endocrinology
    Year: 2023
    Volume: 11(6), 402–413
    Citations: 11
  • Title: Pathophysiological and Laboratory Aspects of Hemostatic Disorders in Patients with COVID-19
    Authors: Đorđević, J., Mihaljević, O., Pirković, M.S., Radović, M., Babović, B.
    Journal: Acta Facultatis Medicae Naissensis
    Year: 2023
    Volume: 40(4), 402–414
    Citations: 0
  • Title: Demographic and Socioeconomic Factors Associated with Cervical Cancer Screening Among Women in Serbia
    Authors: Djordjevic, S., Boricic, K., Radovanovic, S., Mihaljevic, O., Jovanovic, V.
    Journal: Frontiers in Public Health
    Year: 2023
    Volume: 11, 1275354
    Citations: 1